Patents by Inventor Daniel F. PRESTON

Daniel F. PRESTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230270844
    Abstract: A multivalent vaccine for preventing CoV infection includes more than one protein antigen derived from antigens encoded within a CoV genome. At least one of the more than one protein antigen derived from antigens encoded within a CoV genome is a protein antigen, RNA-encoded genetic information, DNA-encoded genetic information, or genetic information within a genetic vector.
    Type: Application
    Filed: July 22, 2021
    Publication date: August 31, 2023
    Inventors: Uwe D. STAERZ, Janae Wheeler CULL, Daniel F. PRESTON, Yan QI
  • Publication number: 20230226170
    Abstract: A vaccine for preventing CoV infection includes at least one DNA, RNA or protein sequence for S protein with at least one modification which is a full deletion or partial deletion of the SI region or a partial or full replacement of the SI region. A method of vaccinating a mammal subject against infection from at least one group of CoV includes separating a broad group of CoV into homology groups, creating a modified S protein containing at least one modification at its S1 region, and identifying at least one consensus sequence for each homology group which has a sequence identity of greater than 60% to all other members of the homology group. The consensus sequence is a protein sequence for the modified S protein, a DNA sequence encoding the modified S protein, and an RNA sequence encoding the modified S protein.
    Type: Application
    Filed: May 12, 2021
    Publication date: July 20, 2023
    Inventors: Uwe D. STAERZ, Daniel F. PRESTON, Yan QI
  • Publication number: 20230210979
    Abstract: A vaccine for preventing ?-CoV infection includes at least one viral vector containing a ?-CoV DNA sequence which codes the S protein for the ?-CoV. The ?-CoV RNA sequence can be a SARS-2 ?-CoV DNA sequence. The vaccine may further includes a packaging plasmid based on an adenovirus. The viral vector and packaging plasmid can be contained in a packaging cell and encapsidated in a capsid. A method of vaccinating a mammal subject against infection from at least one group of ?-CoV includes separating a broad group of ?-CoV into homology groups based on similarities in the ?-CoV RNA sequences which code for their S proteins, identifying at least one consensus sequence for each homology group which has a sequence identity of greater than 60% to all other members of the homology group, and preparing a viral vector including at least a portion of the consensus sequence from at least one homology group.
    Type: Application
    Filed: April 20, 2021
    Publication date: July 6, 2023
    Inventors: Uwe D. STAERZ, Daniel F. PRESTON